Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5791 USD | -0.43% |
|
-9.52% | -28.51% |
07-01 | HOOKIPA Pharma Reports First Patient Dosed in HIV Treatment Study | MT |
07-01 | HOOKIPA Pharma Inc. Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.51% | 57.3M | |
+54.07% | 809B | |
+38.59% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+13.40% | 238B | |
+0.61% | 221B | |
+13.24% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- HOOK Stock
- News HOOKIPA Pharma Inc.
- HOOKIPA Pharma Reports First Patient Dosed in HIV Treatment Study